Hepatic steatosis is a key histological feature of nonalcoholic fatty liver disease (NAFLD).
The non-invasive quantification of liver fat is now possible due to advances in imaging …

Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease that
occurs in the setting of insulin resistance and increased adiposity. It has rapidly evolved into …

Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver
disease worldwide, and the progressive form of this condition, nonalcoholic steatohepatitis …

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of diffuse liver disease. An
accurate estimate of the fat in the liver is important in the diagnostic work-up of patients with …

Background Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity that
requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non …

Traditionally a disease of hepatologists, nonalcoholic fatty liver disease (NAFLD) has
recently become a major concern for a broad spectrum of health care providers …

Non-alcoholic fatty liver disease (NAFLD) represents one of the most common causes of
chronic liver disease, and its prevalence is rising worldwide. The occurrence of non …

Purpose The nonalcoholic fatty liver disease is the most common liver abnormality. Up to
date, liver biopsy is the reference standard for direct liver steatosis quantification in hepatic …

Background & Aims Little is known about the heritability of hepatic fibrosis, and the
heritability of hepatic steatosis has not been assessed systematically in adults. We …